ASSESSMENT OF EFFICACY OF LEUKOTRIENE RECEPTOR ANTAGONISTS IN THERAPY OF BRONCHIAL ASTHMA IN CHILDREN
The article provides data regarding the clinical efficacy and safety of leukotriene receptor antagonists in treatment of bronchial asthma in children. The only representative of this group that is allowed in Russia for treatment of children over 6 years of age is Montelukast. Approval of new 4 mg do...
Main Authors: | Yu.G. Levina, L.S. Namazova-Baranova |
---|---|
Format: | Article |
Language: | English |
Published: |
Paediatrician Publishers, LLC
2009-08-01
|
Series: | Pediatričeskaâ Farmakologiâ |
Online Access: | https://pf.spr-journal.ru/jour/article/view/990 |
Similar Items
-
ASSESSMENT OF EFFICACY OF LEUKOTRIENE RECEPTOR ANTAGONISTS IN THERAPY OF BRONCHIAL ASTHMA IN CHILDREN
by: Yu.G. Levina, et al.
Published: (2009-08-01) -
MODERN VIEW ON THE LONG ACTING β2-AGONISTS IN THERAPY FOR THE BRONCHIAL ASTHMA AMONG CHILDREN
by: Yu.G. Levina, et al.
Published: (2008-05-01) -
MODERN VIEW ON THE LONG ACTING β2-AGONISTS IN THERAPY FOR THE BRONCHIAL ASTHMA AMONG CHILDREN
by: Yu.G. Levina, et al.
Published: (2008-05-01) -
UNCONTROLLED BRONCHIAL ASTHMA IN CHILDREN
by: L.S. Namazova-Baranova
Published: (2009-08-01) -
UNCONTROLLED BRONCHIAL ASTHMA IN CHILDREN
by: L.S. Namazova-Baranova
Published: (2009-08-01)